Intercept Pharmaceuticals Inc

ICPT

Sector
Healthcare

Industry
Biotechnology




Buy / Sell (dollars)

1 Month

99.6% 99.6% Complete (success)
0.4% 0.4% Complete (danger)
$9.311M
avg. $9.311M
$41,025.60
avg. $41,025.60

Buy/Sell Ratio

226.962

Transactions

9

Filers

3

3 Month

96.2% 96.2% Complete (success)
3.8% 3.8% Complete (danger)
$9.311M
avg. $3.104M
$372,248.47
avg. $124,082.82

Buy/Sell Ratio

25.014

Transactions

19

Filers

8

12 Month

5.7% 5.7% Complete (success)
94.3% 94.3% Complete (danger)
$10.528M
avg. $877,346.98
$173.019M
avg. $14.418M

Buy/Sell Ratio

0.061

Transactions

152

Filers

21

24 Month

30.6% 30.6% Complete (success)
69.4% 69.4% Complete (danger)
$76.603M
avg. $3.192M
$173.741M
avg. $7.239M

Buy/Sell Ratio

0.441

Transactions

185

Filers

22

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers